Royal DSM sees 10% local sales growth in Q2

Royal DSM NV, the world's biggest maker of vitamins, said it expects more than 10 percent revenue growth in China in the second quarter of this year compared to the same period last year.

The new prediction comes as it continues a major expansion phase amid the country's fast industrial and consumption upgrading boom, its chairman said on Thursday.

DSM Chairman Feike Sijbesma did not put a figure to the Q2 sales, but its full year earnings report showed that the company's China business accounted for 12 percent of total sales revenue in 2016, reaching over 7.6 billion yuan ($1.12 billion).